Goldman Sachs’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

Goldman Sachs’s Portfolio MR Stock Details MR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-56,600	Closed	-$1.49M	–	7482
2014 Q4	$1.49M	Buy	56,600 +31,600	+126%	+$925K	﹤0.01%	4146
2014 Q3	$754K	Buy	+25,000	New	+$774K	﹤0.01%	4903
2014 Q2	–	Sell	-45,000	Closed	-$1.46M	–	7274
2014 Q1	$1.46M	Sell	45,000 -314,600	-87%	-$11M	﹤0.01%	4302
2013 Q4	$13.1M	Buy	359,600 +42,400	+13%	+$1.65M	﹤0.01%	2121
2013 Q3	$12.3M	Buy	+317,200	New	+$12.8M	﹤0.01%	2037

Other funds holding MR

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Goldman Sachs's MR Position: Q1 2016 in Review

Goldman Sachs sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q1 2016, closing a stake of 291,047 shares — an estimated $7.89M sold.

Goldman Sachs first reported a position in MR in Q2 2013 and held it in 11 quarters. The position peaked at $8.01M in Q4 2013. 2 funds tracked by Wall St. Rank hold MR as of Q1 2016.

Goldman Sachs reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q1 2016 after selling out during the quarter.
Goldman Sachs sold 291,047 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q1 2016, an estimated $7.89M.
Goldman Sachs first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q2 2013 and held it in 11 quarters.
Goldman Sachs's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $8.01M in Q4 2013.
2 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q1 2016.

Based on Goldman Sachs's 13F filing for Q1 2016, filed 13 May 2016.